2m 2m 2m 2m 2m 2m 2m
ICU Medical (ICUI)
NASDAQ
$135.66-$0.48 (-0.35%)
Price as of Jun 23, 2026 4:11 PM EDT- $3.4BMarket Cap
- 6.30%1-Year Change
- Medical Instruments & SuppliesIndustry
ICU Medical (ICUI)
$135.66-$0.48 (-0.35%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.2B -6.33% | 2.4B +5.44% | 2.3B -0.92% | 2.3B +73.21% | |
Cost of Revenue | 1.4B -9.51% | 1.6B +2.50% | 1.5B -3.98% | 1.6B +91.83% | |
Gross Profit | 822.0M -0.33% | 824.8M +11.48% | 739.9M +6.04% | 697.8M +41.97% | |
Sales and Marketing Expense | 625.2M -2.12% | 638.8M +5.29% | 606.7M -0.27% | 608.3M +101.05% | |
Research and Development Expense | -87.5M -1.26% | -88.6M +3.83% | -85.3M -8.22% | -93.0M +95.76% | |
Depreciation and Amortization Expense | 200.7M -8.55% | 219.5M -4.05% | 228.8M -2.71% | 235.2M +162.16% | |
Total Operating Expenses | 779.2M -0.33% | 781.8M +9.03% | 717.0M -3.19% | 740.7M +101.13% | |
Operating Profit | 42.8M -0.31% | 43.0M +88.23% | 22.8M +153.21% | -42.9M -134.81% | |
Interest Income | 10.3M -4.46% | 10.8M +43.69% | 7.5M +69.48% | 4.4M N/A | |
Interest Expense | -83.0M -13.29% | -95.8M +0.56% | -95.2M +43.46% | -66.4M +7,636.01% | |
Interest Income and Expense and Net | -72.7M -14.41% | -85.0M -3.13% | -87.7M +41.59% | -61.9M +7,119.70% | |
Total Nonoperating Income and Expense | -232,000 -98.25% | -13.2M +123.93% | -5.9M +14.97% | -5.1M -742.80% | |
Income before Taxes | 4.4M +106.60% | -66.0M -15.69% | -78.3M -31.56% | -114.4M -192.88% | |
Income Taxes | 2.4M -95.28% | 51.7M +206.23% | -48.6M +21.24% | -40.1M -300.10% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 732,000 +100.62% | -117.7M +296.86% | -29.7M -60.08% | -74.3M -172.03% | |
Net Income from Continuing Operations Applicable to Common | 732,000 +100.62% | -117.7M +296.86% | -29.7M -60.08% | -74.3M -172.03% | |
Basic EPS and Net Income | 0.03 +100.62% | -4.83 +292.68% | -1.23 -60.45% | -3.11 -163.99% | |
Diluted EPS and Net Income | 0.03 +100.62% | -4.83 +292.68% | -1.23 -60.45% | -3.11 -165.61% | |
Basic Weighted Average Shares | 24.6M +1.03% | 24.4M +1.23% | 24.1M +0.93% | 23.9M +12.55% | |
Diluted Weighted Average Shares | 24.9M +2.12% | 24.4M +1.23% | 24.1M +0.93% | 23.9M +9.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 308.0M -0.20% | 308.6M +21.38% | 254.2M +21.76% | 208.8M -62.23% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 501,000 -88.14% | 4.2M -70.71% | |
Cash and Cash Equivalents and Short-Term Investments | 308.0M -0.20% | 308.6M +21.14% | 254.7M +19.58% | 213.0M -62.45% | |
Total Current Assets | 1.2B -17.44% | 1.4B +18.07% | 1.2B -1.13% | 1.2B +19.94% | |
Accumulated Depreciation | 645.9M +8.94% | 592.9M -4.97% | 623.9M +18.51% | 526.4M +20.54% | |
Property and Plant and Equipment and Net | 451.8M +2.05% | 442.7M -27.76% | 612.9M -3.65% | 636.1M +35.82% | |
Total Long-Term Assets | 62.9M -7.72% | 68.1M -27.53% | 94.0M -10.85% | 105.5M +65.45% | |
Total Assets | 4.1B -3.65% | 4.2B -3.99% | 4.4B -3.04% | 4.5B +140.10% | |
Income Taxes Payable | 82.8M -18.24% | 101.2M +2.63% | 98.6M -43.31% | 174.0M +729.97% | |
Total Short-Term Debt | 18.8M -63.24% | 51.0M 0.00% | 51.0M +71.79% | 29.7M -80.21% | |
Total Current Liabilities | 498.9M -10.31% | 556.2M +15.43% | 481.8M -2.57% | 494.6M +146.32% | |
Total Long-Term Debt | 1.3B -17.36% | 1.5B -2.91% | 1.6B -2.83% | 1.6B +91.02% | |
Total Long-Term Liabilities | 75.5M -22.65% | 97.6M -12.63% | 111.7M -55.66% | 252.0M +8,356.85% | |
Total Liabilities | 498.9M -10.31% | 556.2M +15.43% | 481.8M -2.57% | 494.6M +146.32% | |
Retained Earnings | 690.9M +0.11% | 690.2M -14.57% | 807.8M -3.54% | 837.5M -8.15% | |
Total Stockholders Equity | 2.1B +8.07% | 2.0B -7.45% | 2.1B +1.60% | 2.1B +29.32% | |
Total Shares Outstanding | 24.7M +0.70% | 24.5M +1.56% | 24.1M +13.44% | 21.3M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 179.8M -11.85% | 204.0M +22.76% | 166.2M +367.51% | -62.1M -123.22% | |
Capital Expenditures | 88.0M +10.92% | 79.4M -5.39% | 83.9M -7.11% | 90.3M +31.76% | |
Cash from Investing Activities | 122.2M +237.40% | -89.0M +1.15% | -87.9M -95.39% | -1.9B +2,005.56% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -311.5M +458.29% | -55.8M +55.09% | -36.0M -102.20% | 1.6B +9,803.81% | |
Financials Ratio | |||||
Gross Margin | 36.84% +6.40% | 34.62% +5.72% | 32.75% +7.01% | 30.60% -18.04% | |
Operating Margin | 1.92% +6.42% | 1.80% +78.53% | 1.01% +153.70% | -1.88% -120.10% | |
Return on Assets | 0.02% +100.65% | -2.74% +311.31% | -0.67% -71.29% | -2.32% -141.04% | |
Return on Equity | 0.04% +100.62% | -5.76% +308.95% | -1.41% -64.89% | -4.01% -160.61% | |
Revenue Growth | -6.33% -216.34% | 5.44% +694.38% | -0.92% -101.25% | 73.21% +1,953.96% | |
Current Ratio | 2.39 -7.95% | 2.59 +2.29% | 2.53 +1.48% | 2.50 -51.31% | |
Cash Ratio | 0.62 +11.27% | 0.55 +5.16% | 0.53 +24.96% | 0.42 -84.67% | |
Debt-to-Equity Ratio | 0.60 -24.89% | 0.81 +4.99% | 0.77 -3.03% | 0.79 +27.84% | |
Debt-to-Assets Ratio | 0.32 -15.75% | 0.38 +1.21% | 0.37 +1.61% | 0.37 -31.15% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow